About a fifth of the population in care centers consider not getting vaccinated against COVID-19



[ad_1]

“Today, there are about 8% of those who have refused to be vaccinated or have not yet made up their minds; It would be better to say so, because the heads and specialists of the institutions constantly communicate and update this data. employees and up to 20%. the deputy minister said at a press conference on Monday.

“There are various fears or fantasies about certain preconceptions. It is no secret that there is a lot of information and false conspiracy theories throughout the online space that have had some influence, “he added.

Residents and employees of nursing and care institutions will start vaccination in Lithuania on Tuesday.

According to the vice minister, some 13,000 people live in the country’s nursing and care institutions, and more than 8,000 people work there. people. About 40 percent. of these have already been infected with COVID-19 and will not be vaccinated.

In addition, rapid antibody tests will be performed prior to vaccination to determine if a person has not been aware of the disease.

“Preliminarily, up to 20 thousand. Vaccination care institutions, here for both doses”, – said V. Augienė.

The first dose is scheduled to be administered to residents and staff of the facility within five days. According to the deputy minister, vaccination is organized by municipal primary health care centers.

“Both tools and vaccines are brought, depending on the divisibility of the package; if the complete package of the vaccine is needed, it is taken directly from the Emergency Warehouse, if necessary, then from the five main centers in Vilnius, Kaunas , Klaipeda, Siauliai and Panevezys “. She talked.

According to data from the Statistics Department on Monday, a total of more than 22.5 thousand people have already been vaccinated in Lithuania. people.

The vaccination was launched in Lithuania in late December with a vaccine developed by BioNTech and Pfizer.

On Wednesday, the European Medicines Agency approved the second vaccine produced by the American company Moderna.



[ad_2]